Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function

por Blaeschke, Franziska, Ortner, Eva, Stenger, Dana, Mahdawi, Jasmin, Apfelbeck, Antonia, Habjan, Nicola, Weißer, Tanja, Kaeuferle, Theresa, Willier, Semjon, Kobold, Sebastian, Feuchtinger, Tobias
Publicado 2022

Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells

por Kaeuferle, Theresa, Stief, Tanja A, Canzar, Stefan, Kutlu, Nayad N, Willier, Semjon, Stenger, Dana, Ferrada‐Ernst, Paulina, Habjan, Nicola, Peters, Annika E, Busch, Dirk H, Feuchtinger, Tobias
Publicado 2022

Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins

por Blaeschke, Franziska, Stenger, Dana, Apfelbeck, Antonia, Cadilha, Bruno L., Benmebarek, Mohamed-Reda, Mahdawi, Jasmin, Ortner, Eva, Lepenies, Mareike, Habjan, Nicola, Rataj, Felicitas, Willier, Semjon, Kaeuferle, Theresa, Majzner, Robbie G., Busch, Dirk H., Kobold, Sebastian, Feuchtinger, Tobias
Publicado 2021